--- title: CPhI Theater 2019 description: The BPI Theater at BIO 2018 - Speakers highlighted new manufacturing techniques that will enable faster speed to market for cell therapies, and flexible manufacturing environments to rapidly shift and produce a variety of biotherapeutic products at clinical and commercial scale. --- - [Subscribe](https://www.sub-forms.com/dragon/init.do?site=INF1_BQland) - | [Contribute](http://www.bioprocessintl.com/about/author-guidelines/) - | [About](http://www.bioprocessintl.com/about/) - | [Register](http://www.bioprocessintl.com/register/) - | [Login](http://www.bioprocessintl.com/login/) |   | | | --- | --- | [ ![BPI Logo_Color](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Logo_Color.png?width=330&height=152&name=BPI%20Logo_Color.png)](http://www.bioprocessintl.com/) - [Upstream Processing](http://www.bioprocessintl.com/topic/upstream-processing/) - Read More concerning Upstream Processing - [Assays](http://www.bioprocessintl.com/category/upstream-processing/assays/) - [Biochemicals/Raw Materials](http://www.bioprocessintl.com/category/upstream-processing/biochemicals-raw-materials/) - [Bioreactors](http://www.bioprocessintl.com/category/upstream-processing/bioreactors/) - [Cell Culture Media](http://www.bioprocessintl.com/category/upstream-processing/fermentation/) - [Expression Platforms](http://www.bioprocessintl.com/category/upstream-processing/fermentation/) - [Fermentation](http://www.bioprocessintl.com/category/upstream-processing/fermentation/) - [Upstream Contract Services](http://www.bioprocessintl.com/category/upstream-processing/upstream-contract-services/) - [Upstream Single-Use Technologies](http://www.bioprocessintl.com/category/upstream-processing/upstream-single-use-technologies/) - [Downstream Processing](http://www.bioprocessintl.com/topic/downstream-processing/) - Read More concerning Downstream Processing - [Filtration](http://www.bioprocessintl.com/category/downstream-processing/filtration/) - [Separation/Purification](http://www.bioprocessintl.com/category/downstream-processing/viral-clearance/) - [Viral Clearance](http://www.bioprocessintl.com/category/downstream-processing/viral-clearance/) - [Chromatography](http://www.bioprocessintl.com/category/downstream-processing/downstream-contract-services/) - [Downstream Contract Services](http://www.bioprocessintl.com/category/downstream-processing/downstream-contract-services/) - [Downstream Single-Use Technologies](http://www.bioprocessintl.com/category/downstream-processing/downstream-single-use-technologies/) - [Manufacturing](http://www.bioprocessintl.com/topic/manufacturing/) - Read More concerning Manufacturing - [Personalized Medicine](http://www.bioprocessintl.com/category/manufacturing/personalized-medicine/) - [Single Use](http://www.bioprocessintl.com/category/manufacturing/vaccines/) - [Supply Chain](http://www.bioprocessintl.com/category/manufacturing/vaccines/) - [Vaccines](http://www.bioprocessintl.com/category/manufacturing/vaccines/) - [Antibody and Nonantibody](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/) - [Biosimilars](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/) - [Cell Therapies](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/) - [Facility Design/Engineering](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/) - [Fill/Finish](http://www.bioprocessintl.com/category/manufacturing/fill-finish/) - [Formulation](http://www.bioprocessintl.com/category/manufacturing/formulation/) - [Information Technology](http://www.bioprocessintl.com/category/manufacturing/information-technology/) - [Manufacturing Contract Services](http://www.bioprocessintl.com/category/manufacturing/manufacturing-contract-services/) - [Analytical](http://www.bioprocessintl.com/topic/analytical/) - Read More concerning Analytical - [Culture Development](http://www.bioprocessintl.com/category/analytical/culture-development/) - [Downstream Development](http://www.bioprocessintl.com/category/analytical/downstream-development/) - [Downstream Validation](http://www.bioprocessintl.com/category/analytical/downstream-validation/) - [Laboratory Equipment](http://www.bioprocessintl.com/category/analytical/laboratory-equipment/) - [PAT](http://www.bioprocessintl.com/category/analytical/pat/) - [Pre-Formulation](http://www.bioprocessintl.com/category/analytical/pre-formulation/) - [Product Characterization](http://www.bioprocessintl.com/category/analytical/product-characterization/) - [QA/QC](http://www.bioprocessintl.com/category/analytical/qa-qc/) - [Upstream Development](http://www.bioprocessintl.com/category/analytical/upstream-validation/) - [Upstream Validation](http://www.bioprocessintl.com/category/analytical/upstream-validation/) - [Leachables/Extractables/Particulates](http://www.bioprocessintl.com/category/analytical/leachables-extractables-particulates/) - [Business](http://www.bioprocessintl.com/topic/business/) - Read More concerning Business - [Careers](http://www.bioprocessintl.com/category/business/careers/) - [CMC Forums](http://www.bioprocessintl.com/category/business/cmc-forums/) - [Economics](http://www.bioprocessintl.com/category/business/economics/) - [Intellectual Property](http://www.bioprocessintl.com/category/business/intellectual-property/) - [Pre-Clinical and Clinical Trials](http://www.bioprocessintl.com/category/business/pre-clinical-and-clinical-trials/) - [Regulatory Affairs](http://www.bioprocessintl.com/category/business/regulatory-affairs/) - [Risk Management](http://www.bioprocessintl.com/category/business/risk-management/) - [BioRegions](http://www.bioprocessintl.com/category/business/bioregions/) - [Home](http://www.bioprocessintl.com/) - [Archive](http://www.bioprocessintl.com/issue-archive/) - [Current Issue](https://bpi.bioprocessintl.com/2017-yearbook) - [Featured Reports](http://www.bioprocessintl.com/featured-reports/) - [eBooks](http://www.bioprocessintl.com/ebooks/) - [Multimedia](http://www.bioprocessintl.com/category/multimedia/) - [Events](http://www.bioprocessintl.com/events-calendar/) - [News](http://www.bioprocessintl.com/category/news/) - [Upstream Processing](http://www.bioprocessintl.com/topic/upstream-processing/) - [Downstream Processing](http://www.bioprocessintl.com/topic/downstream-processing/) - [Manufacturing](http://www.bioprocessintl.com/topic/manufacturing/) - [Analytical](http://www.bioprocessintl.com/topic/analytical/) - [Business](http://www.bioprocessintl.com/topic/business/) ![BPI-Theater-header](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI-Theater-header.jpg?width=1200&name=BPI-Theater-header.jpg "BPI-Theater-header") | *These presentations, interviews, and panel discussions took place at the 2019 CPhI bioLive Theater. Focusing on technology strategies for biopharmaceutical manufacturing, emerging therapies, and tools for process optimization that will be of interest to BPI readers and the CPhI attendees. Speakers highlighted manufacturing bottlenecks, new technologies to overcome those obstacles, and ADCs and bioconjugates. View the full presentations at the links below.* | | --- | | [![McNaull_Tues3.jpg](https://bioprocessintl.com/wp-content/uploads/2019/07/Stanton-singleuse.jpg "Stanton_SU.jpg")](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/industrys-uptake-of-single-use-technology-and-how-it-has-driven-vendor-consolidation-a-business-journalists-point-of-view/) [**Industry’s Uptake of Single-Use Technology and How it Has Driven Vendor Consolidation: A Business Journalist’s Point of View**](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/industrys-uptake-of-single-use-technology-and-how-it-has-driven-vendor-consolidation-a-business-journalists-point-of-view/) | | --- | | [![Patterson_Tues.jpg](https://bioprocessintl.com/wp-content/uploads/2019/07/Patterson.jpg "Peter_Tues5.jpg")](https://bioprocessintl.com/sponsored-content/single-use-technology-for-containment-during-adc-handling/) [**Single-Use Technology for Containment During ADC Handling**](https://bioprocessintl.com/sponsored-content/single-use-technology-for-containment-during-adc-handling/) | | --- | | [![Tues-Panel.jpg](https://bioprocessintl.com/wp-content/uploads/2019/07/2019-CPhI-Roundtable-1-Snip.png)](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/how-has-single-use-increased-access-to-biomanufacturing-solutions-for-both-cdmos-and-end-users/) [**How Has Single-Use Increased Access to Biomanufacturing Solutions for Both CDMOs and End-Users?**](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/how-has-single-use-increased-access-to-biomanufacturing-solutions-for-both-cdmos-and-end-users/) | | --- | | [![Page_Weds.jpg](https://bioprocessintl.com/wp-content/uploads/2019/07/Cordova-Snip-557x317.png "Cordova-Tues.jpg")](https://bioprocessintl.com/sponsored-content/reducing-risk-and-improving-timelines-in-the-design-development-and-manufacture-of-antibody-drug-conjugates/) [**Reducing Risk and Improving Timelines in the Design, Development, and Manufacture of Antibody Drug Conjugates**](https://bioprocessintl.com/sponsored-content/reducing-risk-and-improving-timelines-in-the-design-development-and-manufacture-of-antibody-drug-conjugates/) | | --- | | [![Panel_Tues6.jpg](https://bioprocessintl.com/wp-content/uploads/2019/07/Ecker-Snip-1-568x314.png "Ecker_Tues.jpg")](https://bioprocessintl.com/sponsored-content/biopharmaceutical-indications-and-targets-past-present-and-future/) [**Biopharmaceutical Indications and Targets: Past, Present, and Future**](https://bioprocessintl.com/sponsored-content/biopharmaceutical-indications-and-targets-past-present-and-future/) | | --- | | [![Miller_Tues.jpg](https://bioprocessintl.com/wp-content/uploads/2019/07/Miller-Snip-1-568x290.png "Miller_Tues.jpg")](https://bioprocessintl.com/sponsored-content/bioconjugation-cmc-successfully-executing-a-complex-process/) [**Bioconjugation CMC: Successfully Executing a Complex Process**](https://bioprocessintl.com/sponsored-content/bioconjugation-cmc-successfully-executing-a-complex-process/) | | --- | | [![Botens](https://bioprocessintl.com/wp-content/uploads/2019/07/2019-CPhI-Roundtable-2-Snip.png "Panel_Tues-pm.jpg")](https://bioprocessintl.com/sponsored-content/how-are-service-companies-responding-to-the-increased-interest-in-new-modalities-and-what-regulatory-and-market-hurdles-still-exist/) [**How Are Service Companies Responding to the Increased Interest in New Modalities, and What Regulatory and Market Hurdles Still Exist?**](https://bioprocessintl.com/sponsored-content/how-are-service-companies-responding-to-the-increased-interest-in-new-modalities-and-what-regulatory-and-market-hurdles-still-exist/) | | --- | | [![Insider-interview-Noonan](https://bioprocessintl.com/wp-content/uploads/2019/07/Morgret-562x317.jpg "Panel_Tues4.jpg")](https://bioprocessintl.com/sponsored-content/cmc-considerations-for-commercial-ready-adc-manufacturing-processes-to-enable-accelerated-timelines/) [**CMC Considerations for Commercial-Ready ADC Manufacturing Processes to Enable Accelerated Timelines**](https://bioprocessintl.com/sponsored-content/cmc-considerations-for-commercial-ready-adc-manufacturing-processes-to-enable-accelerated-timelines/) | | --- | | [![Insider-interview-Noonan](https://bioprocessintl.com/wp-content/uploads/2019/07/2019-CPhI-Theater-MKS-568x291.png "Panel_Tues4.jpg")](https://bioprocessintl.com/sponsored-content/commercialization-frameworks-for-the-biopharma-ecosystem/) [**Commercialization Frameworks for the Biopharma Ecosystem**](https://bioprocessintl.com/sponsored-content/commercialization-frameworks-for-the-biopharma-ecosystem/) | | --- | | [![ladoux-tues](https://bioprocessintl.com/wp-content/uploads/2019/07/LaDoux-561x317.jpg)](https://bioprocessintl.com/sponsored-content/scaling-multi-column-chromatography-to-the-production-suite/) [**Scaling Multi-Column Chromatography to the Production Suite**](https://bioprocessintl.com/sponsored-content/scaling-multi-column-chromatography-to-the-production-suite/) | | --- | | [![Bottlenecks-panel-CPhI](https://bioprocessintl.com/wp-content/uploads/2019/07/CPhI-panel3.jpg)](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/where-are-todays-biomanufacturing-bottlenecks-and-how-is-industry-looking-to-overcome-them/) [**Where Are Today’s Biomanufacturing Bottlenecks and How Is Industry Looking to Overcome Them?**](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/where-are-todays-biomanufacturing-bottlenecks-and-how-is-industry-looking-to-overcome-them/) | | --- | | [![](https://bioprocessintl.com/wp-content/uploads/2019/07/Davies-561x317.jpg "Andy-Davies")](https://bioprocessintl.com/sponsored-content/flow-through-polishing-and-the-use-of-multimode-ligand-libraries-to-improve-process-efficiencies/) [**Flow-Through Polishing and the Use of Multimode Ligand Libraries to Improve Process Efficiencies**](https://bioprocessintl.com/sponsored-content/flow-through-polishing-and-the-use-of-multimode-ligand-libraries-to-improve-process-efficiencies/) | | --- | | [![](https://bioprocessintl.com/wp-content/uploads/2019/07/Langer-561x317.jpg "Eric-Langer")](https://bioprocessintl.com/sponsored-content/chinas-focus-on-innovation-investment-in-product-and-process-development-innovative-technologies-from-china-are-coming/) [**China’s Focus on Innovation: Investment in Product and Process Development — Innovative Technologies from China are Coming**](https://bioprocessintl.com/sponsored-content/chinas-focus-on-innovation-investment-in-product-and-process-development-innovative-technologies-from-china-are-coming/) | | --- | | [![](https://bioprocessintl.com/wp-content/uploads/2019/07/Achenbach-562x317.jpg "Achenbach")](https://bioprocessintl.com/sponsored-content/biopharmaceutical-raw-materials-changes-supply-chain/) [**Biopharma as a Maturing Industry**](https://bioprocessintl.com/sponsored-content/biopharmaceutical-raw-materials-changes-supply-chain/) | | --- | | [![](https://bioprocessintl.com/wp-content/uploads/2019/07/CPhI-panel4.jpg "Weds-PM Panel")](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/at-what-point-in-drug-development-must-a-firm-look-to-process-optimization-and-how-critical-is-this-timing-to-a-products-overall-success/) [**At What Point in Drug Development Must a Firm Look to Process Optimization, and How Critical is this Timing to a Product’s Overall Success?**](https://bioprocessintl.com/bpi-theater/bpi-theater-cphi-2019/at-what-point-in-drug-development-must-a-firm-look-to-process-optimization-and-how-critical-is-this-timing-to-a-products-overall-success/) | | --- | -   -   ©2015 BioProcess International All Rights reserved